Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Journal:
Current Drug Targets
Volume:
10
Page:
158-175
Author(s):
P. M. Deckert
Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
753-779
Author(s):
P. Nieri, D. Donadio, S. Rossi, B. Adinolfi and A. Podesta
Role of Metallothionein in Inflammatory Lung Diseases
Journal:
Current Respiratory Medicine Reviews
Volume:
5
Page:
6-11
Author(s):
Ken-ichiro Inoue, Hirohisa Takano, Akinori Shimada and Masahiko Satoh
Radiosensitizing Potential of Epigenetic Anticancer Drugs
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
99-108
Author(s):
Harlinde De Schutter and Sandra Nuyts
Marine Sponges: Potential Sources of New Antimicrobial Drugs
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
86-105
Author(s):
M. S. Laport, O. C.S. Santos and G. Muricy
Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
3
Page:
1-16
Author(s):
Simon A. Hirota, Paul L. Beck and Justin A. MacDonald
Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
3790-3801
Author(s):
Carlo Bifulco, Katy McDaniel, Lin Leng and Richard Bucala
Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Journal:
Current Drug Metabolism
Volume:
9
Page:
1063-1120
Author(s):
C. Ulbricht, W. Chao, D. Costa, E. Rusie-Seamon, W. Weissner and J. Woods
Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
8
Page:
375-392
Author(s):
Myriam Chentouf, Maxime Rigo, Andre Pelegrin and Thierry Chardes
Novel Virally Targeted Therapies of EBV-Associated Tumors
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
581-596
Author(s):
Paolo De Paoli